Cytokines as Biomarkers of Treatment Response to IFNβ in Relapsing-Remitting Multiple Sclerosis

Background. MS patients show a remarkable heterogeneity in their response to disease modifying treatments. Given the need for early treatment initiation and the diversity of available options, a predictive marker that indicates good or poor response to treatment is highly desirable. Objective. To fi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Dimisianos, Nikolaos, Rodi, Maria, Kalavrizioti, Dimitra, Georgiou, Vasileios, Papathanasopoulos, Panagiotis, Mouzaki, Athanasia
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4134814/
https://ncbi.nlm.nih.gov/pubmed/25152817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/436764
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars